【PD1】

Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products

constitutes a patent infringement. The current list only reflects the products and technologies that are available,

under development: note that some products may be developed or produced for internal and experimental uses

with no commercal aim.

【PD2】

Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and

development quantities.

【PD3】

the buyer assumes responsibility of all patent considerations in the use of
Chemieliva Pharmaceutical Co., Ltd product(s).

Acinopeptide Co., Ltd

Pharmten Chemical Co., Ltd

【PD4】

R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law

in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of

the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of

Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of s

ame by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become

applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other

countries.

 


  重慶福騰醫藥化工有限公司
极速赛车开奖网 创新平台 2018最准六肖公式规律 pk10牛牛 淘宝快3玩法 全民麻将官网下载 广东十一选五合双 闲来麻将游戏币提现 时时彩四星计划软件 排列三哪个电视台开奖 psv什么游戏好玩 个性车贴店赚钱吗 保研论坛怎样赚钱 nba比分猜测 怎么看足球盘囗水位 掌心诈金花 重庆幸运农场中奖规则